Related Experiment Videos
Hepatocellular carcinoma monitored by F-18 fluorodeoxyglucose positron emission tomography after laparoscopic
H Morikawa1, S Shiomi, N Sasaki
1Third Department of Internal Medicine, Osaka City University Medical School, Osaka, Japan.
Clinical Nuclear Medicine
|July 13, 1999
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Stable transformation of Eustoma grandiflorum by particle bombardment.
Plant cell reports·2019
Establishment of educational program for multiorgan procurement from deceased donors.
Transplantation proceedings·2014
Effect of temperature on membrane fluidity and protoplast fusion.
TAG. Theoretical and applied genetics. Theoretische und angewandte Genetik·2013
One Tracer, Whole Syndrome: CAIX-Targeted PET Unmasks the Multisystem Tumor Landscape of Von Hippel-Lindau Disease.
Clinical nuclear medicine·2026
18F-FET PET Pitfall in Pituitary Imaging: False-positive Uptake Due to Neurosarcoidosis.
Clinical nuclear medicine·2026
Reversing the Reverse: Nitrate-Enhanced Tc-99m MIBI MPS Unmasking Microvascular Dysfunction in Takayasu Arteritis.
Clinical nuclear medicine·2026
The "Scintigraphic Flip": A Visual Warning Sign of Impending Hematologic Toxicity.
Clinical nuclear medicine·2026
Radiation Exposure in Elective Endovascular Carotid Artery Stenting.
Clinical neuroradiology·2026
Early functional and oncological outcomes after robot-assisted radical prostatectomy in D'Amico high-risk prostate cancer: a prospective cohort study.
Archivio italiano di urologia, andrologia : organo ufficiale [di] Societa italiana di ecografia urologica e nefrologica·2026
Risk Factors for Pathologic Fracture in Dogs With Confirmed or Suspected Appendicular Osteosarcoma Treated With Low- or Standard-Dose-Rate Palliative External Beam Radiation Therapy.
Veterinary radiology & ultrasound : the official journal of the American College of Veterinary Radiology and the International Veterinary Radiology Association·2026
Kidney impairment post 177Lu-PSMA radioligand therapy in metastatic prostate cancer.
Nuclear medicine communications·2026